NTI164 Human PK Study

NCT06713447 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Healthy Volunteer

Interventions

DRUG: NTI164

Sponsor

Fenix Innovation Group

Collaborators

[object Object]
[object Object]